Delivery Order SPE2DB20D3103-SPE2DB25FP2N3
Award Date 6/23/25
Potential Completion Date 6/24/25
Potential Value $8.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,120.74 fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 3, 2025 and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,966.07. The contract is a firm fixed price delivery order, without a set-aside designation, and has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $11,131.76 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 15, 2025, with a completion date of July 16, 2025. The contract is not a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The $7,434.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 19, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $15,486.20 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and is not designated as a set-aside contract. The award has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA). The $9,738.66 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp on December 19, 2024, with a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The $9,014.06 firm fixed price contract was awarded on July 16, 2025 with a completion date of July 17, 2025. The awardee is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not a set-aside award. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,506.64 and is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 8, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the pharmaceutical product OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML. The $29,470.92 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The $14,230.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 21, 2025, with a completion date of May 22, 2025. The contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a...